The Recall Desk
SevereFDA (Drugs)·D-1712-2019·Announced 2019-08-14

RXQ Compounding Recalls Turbo Caine 2.5 Due to Sterility Concerns

RXQ Compounding LLC is recalling Turbo Caine 2.5 syringes because the FDA determined there is a lack of assurance of sterility.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The FDA classified this recall as Class II. According to the severity rubric, an FDA Class II recall involving a risk of harm (lack of sterility) where injury has not yet been reported is categorized as Severe (Score 4), as it exceeds the criteria for High (Score 3) which typically applies to theoretical risks or specific high-risk pathogens without reported illness, but Class II implies a higher potential for adverse health consequences than Class III.

Plain-English summary

RXQ Compounding LLC is voluntarily recalling Turbo Caine 2.5 (PHEN2.5/CYCLO1/TROP1/TETRA 0.5), 0.4 mL per syringe, under FDA recall number D-1712-2019. The product is a compounded medication containing phenylephrine, cyclopentolate, tropicamide, and tetracaine.

The recall was initiated due to a lack of assurance of sterility. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

The affected product was distributed nationwide in the United States. All lots within the expiration date are included in this recall. Patients who have received this medication should contact their healthcare provider for further instructions.

The recalled product

Product
TURBO CAINE 2.5 (PHEN2.5/CYCLO1/ TROP1/TETRA 0.5), 0.4 ML per Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0193-81
Manufacturer
RXQ Compounding LLC
Category
Drug — Compounded Medication
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 86 recalled by RXQ Compounding LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 86 products in this recall →

Related recalls

Same manufacturer · RXQ Compounding LLC

See all →

Same hazard · lack of sterility

See all →